Our venture capital arm was initiated in January 2000 with the establishment of a US$26 million fund. We invest in companies in the ICT, biotechnology and life sciences sectors, focusing on those with high growth market potential, competitive advantage, innovative niche technologies and proven management. Our investments include those in various stages of development and commercialisation, and are spread in various countries including the UK, Korea, Singapore and Malaysia.

We believe in bringing value to our investments, by expanding our role beyond fund provides, to include active management of our portfolio, providing strategic level input, financial advisory and introductions to our wide network.

Our stable of companies has grown to include THG Capital Sdn Bhd (“THG Capital”), a venture capital company, and Amazon Plus Sdn Bhd to undertake asset management and financial advisory services. We also believe in exploiting marketing opportunities in introducing proven technologies and business models from our venture capital network, to this part of the world and have established Strategic Starview Sdn Bhd to spearhead this area.

Other than our own fund, we have launched two partnership funds with other prominent investors. The first partnership fund, Ginosko Technology Investments, is in collaboration with the Singapore Economic Development Board, TIF Ventures Pte Ltd, focusing in investments in the ICT sector. Spring Hill Bioventures, the second fund, is with Khazanah Nasional Berhad, Great Eastern Life Assurance (Malaysia Berhad) and PacificMas Fidelity Sdn Bhd, a US$30 million biotechnology fund, managed by prominent biotech entrepreneur, Dr Kim Tan. The Spring Hill fund has since made numerous investments, including several biotech related projects to be based in Penang.


TH Group Berhad has been listed on the Main Board of Bursa Malaysia Securities Berhad (Kuala Lumpur Stock Exchange) since 1 March 1999 under the Plantation Sector. TH Group is a well diversified group of companies, with four principal divisions namely Plantation, Contracting, Biohealthcare and Information Technology.

Under the Plantation division, the Group has cultivated approximately 11,469 hectares of palm oil plantations in the state of Sabah, Malaysia, and operates a 90 metric tonne palm oil mill that produces crude palm oil and palm kernel.

As for Contracting division, the Group is involved in coal mining contracting services, as well as design and build, civil and infrastructure construction projects.

In the Biohealthcare division, the Group operates the NCI Cancer Hospital in Nilai, Negeri Sembilan, a pharmaceutical distribution unit under Asiaprise Pharma Sdn Bhd, in addition to the investment in biotechnology ventures.

The Information Technology division is mainly involved in sales, implementation as well as research and development of oil palm plantation and milling softwares.

Notify of
Inline Feedbacks
View all comments